Probing Early Myocardial Remodeling in Response to a High-Fat Diet in Mice by Evaluation of Extracellular Volume Fraction Using 4D Retrospectively Gated Micro-CT Imaging.
IF 2.5 4区 医学Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Grzegorz Kwiatkowski, Anna Gąsiorek, Izabela Ciastoń, Joanna Kozieł, Greetje Vande Velde, Stefan Chłopicki
{"title":"Probing Early Myocardial Remodeling in Response to a High-Fat Diet in Mice by Evaluation of Extracellular Volume Fraction Using 4D Retrospectively Gated Micro-CT Imaging.","authors":"Grzegorz Kwiatkowski, Anna Gąsiorek, Izabela Ciastoń, Joanna Kozieł, Greetje Vande Velde, Stefan Chłopicki","doi":"10.1007/s11307-026-02111-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The objective of this study was to evaluate whether retrospectively gated 4D micro-computed tomography (µCT) can quantify extracellular volume fraction (ECV) as an early marker of myocardial fibrosis and remodeling in a high-fat diet (HFD) mouse model, and to determine its relationship with cardiac functional parameters.</p><p><strong>Procedures: </strong>Male C57BL/6J mice were assigned to control diet or high-fat diet (HFD) groups, with HFD animals imaged after 8 or 16 weeks of feeding and control animals scanned at an age-matched time point. Contrast-enhanced 4D µCT with ECG gating was performed for cardiac function analysis and pre/post-contrast imaging for ECV quantification, corrected for hematocrit. Functional measures included left ventricular (LV) volumes, ejection fraction, mitral annular plane systolic excursion (MAPSE), circumferential shortening, and dobutamine stress response.</p><p><strong>Results: </strong>Global LV ECV significantly increased at 8 weeks of HFD compared to controls, preceding changes in LV mass and ejection fraction. Early ECV elevation correlated with impaired lateral MAPSE, indicating subtle functional impairment despite preserved global systolic function. At 16 weeks, further remodeling was evident with increased LV mass, reduced epicardial circumferential shortening, decreased left atrial ejection area, and diminished dobutamine-induced contractile reserve.</p><p><strong>Conclusions: </strong>Retrospectively gated 4D µCT provides a robust and noninvasive method for early detection of diffuse myocardial fibrosis and functional impairment in small animal models. This approach enables longitudinal studies of cardiac disease progression and therapeutic interventions, offering translational value for preclinical cardiology research.</p>","PeriodicalId":18760,"journal":{"name":"Molecular Imaging and Biology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11307-026-02111-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The objective of this study was to evaluate whether retrospectively gated 4D micro-computed tomography (µCT) can quantify extracellular volume fraction (ECV) as an early marker of myocardial fibrosis and remodeling in a high-fat diet (HFD) mouse model, and to determine its relationship with cardiac functional parameters.
Procedures: Male C57BL/6J mice were assigned to control diet or high-fat diet (HFD) groups, with HFD animals imaged after 8 or 16 weeks of feeding and control animals scanned at an age-matched time point. Contrast-enhanced 4D µCT with ECG gating was performed for cardiac function analysis and pre/post-contrast imaging for ECV quantification, corrected for hematocrit. Functional measures included left ventricular (LV) volumes, ejection fraction, mitral annular plane systolic excursion (MAPSE), circumferential shortening, and dobutamine stress response.
Results: Global LV ECV significantly increased at 8 weeks of HFD compared to controls, preceding changes in LV mass and ejection fraction. Early ECV elevation correlated with impaired lateral MAPSE, indicating subtle functional impairment despite preserved global systolic function. At 16 weeks, further remodeling was evident with increased LV mass, reduced epicardial circumferential shortening, decreased left atrial ejection area, and diminished dobutamine-induced contractile reserve.
Conclusions: Retrospectively gated 4D µCT provides a robust and noninvasive method for early detection of diffuse myocardial fibrosis and functional impairment in small animal models. This approach enables longitudinal studies of cardiac disease progression and therapeutic interventions, offering translational value for preclinical cardiology research.
期刊介绍:
Molecular Imaging and Biology (MIB) invites original contributions (research articles, review articles, commentaries, etc.) on the utilization of molecular imaging (i.e., nuclear imaging, optical imaging, autoradiography and pathology, MRI, MPI, ultrasound imaging, radiomics/genomics etc.) to investigate questions related to biology and health. The objective of MIB is to provide a forum to the discovery of molecular mechanisms of disease through the use of imaging techniques. We aim to investigate the biological nature of disease in patients and establish new molecular imaging diagnostic and therapy procedures.
Some areas that are covered are:
Preclinical and clinical imaging of macromolecular targets (e.g., genes, receptors, enzymes) involved in significant biological processes.
The design, characterization, and study of new molecular imaging probes and contrast agents for the functional interrogation of macromolecular targets.
Development and evaluation of imaging systems including instrumentation, image reconstruction algorithms, image analysis, and display.
Development of molecular assay approaches leading to quantification of the biological information obtained in molecular imaging.
Study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics.
Extension of in vitro and in vivo discoveries using disease models, into well designed clinical research investigations.
Clinical molecular imaging involving clinical investigations, clinical trials and medical management or cost-effectiveness studies.